143 related articles for article (PubMed ID: 36440796)
1. Efficacy and safety of intravenous iron sucrose in children younger than 2 years with intestinal failure.
Lepus CA; Samela K; Mokha JS
Nutr Clin Pract; 2023 Aug; 38(4):899-903. PubMed ID: 36440796
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
Stein RE; Plantz K; Maxwell EC; Mamula P; Baldassano RN
J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e51-e55. PubMed ID: 28704225
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of parenteral iron in children with inflammatory bowel disease.
Papadopoulos M; Patel D; Korologou-Linden R; Goto E; Soondrum K; Fell JME; Epstein J
Br J Clin Pharmacol; 2018 Apr; 84(4):694-699. PubMed ID: 29266387
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis.
Shin HW; Go DY; Lee SW; Choi YJ; Ko EJ; You HS; Jang YK
Medicine (Baltimore); 2021 May; 100(20):e24571. PubMed ID: 34011020
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Derman R; Roman E; Modiano MR; Achebe MM; Thomsen LL; Auerbach M
Am J Hematol; 2017 Mar; 92(3):286-291. PubMed ID: 28052413
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
Kaneva K; Chow E; Rosenfield CG; Kelly MJ
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e259-e262. PubMed ID: 28562517
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis].
Ding SX; Zhao YH; Wang T; Guan J; Xing LM; Liu H; Wang GJ; Wang XM; Wu YH; Qu W; Song J; Wang HQ; Li LJ; Shao ZH; Fu R
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):178-183. PubMed ID: 38604795
[No Abstract] [Full Text] [Related]
8. Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose.
Hu S; Liu L; Pollock RF; Pöhlmann J; Wu D; Zhang Y
J Med Econ; 2022; 25(1):561-570. PubMed ID: 35403540
[TBL] [Abstract][Full Text] [Related]
9. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy.
Crary SE; Hall K; Buchanan GR
Pediatr Blood Cancer; 2011 Apr; 56(4):615-9. PubMed ID: 21298748
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
Ikuta K; Hanashi H; Hirai K; Ota Y; Matsuyama Y; Shimura A; Terauchi M; Momoeda M
Int J Hematol; 2019 Jan; 109(1):41-49. PubMed ID: 30039442
[TBL] [Abstract][Full Text] [Related]
11. Analysis of transition from intravenous iron sucrose to ferric carboxymaltose infusions in pediatric patients with intestinal failure.
Kaenkumchorn TK; Rosete BE; Carlin K; Fukasawa S; Horslen SP; Wendel D
JPEN J Parenter Enteral Nutr; 2022 Sep; 46(7):1578-1584. PubMed ID: 35616288
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
Michaud L; Guimber D; Mention K; Neuville S; Froger H; Gottrand F; Turck D
Clin Nutr; 2002 Oct; 21(5):403-7. PubMed ID: 12381338
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron sucrose for children with iron deficiency anemia: a single institution study.
Mantadakis E; Tsouvala E; Xanthopoulou V; Chatzimichael A
World J Pediatr; 2016 Feb; 12(1):109-13. PubMed ID: 25754747
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery.
Auerbach M; Achebe MM; Thomsen LL; Derman RJ
Obes Surg; 2022 Mar; 32(3):810-818. PubMed ID: 35000068
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron for critically ill children. Comparison of three dose regimens.
Butragueño-Laiseca L; de la Mata Navazo S; Sánchez Galindo AC; Santiago Lozano MJ
Pediatr Blood Cancer; 2024 Jan; 71(1):e30734. PubMed ID: 37880937
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
Wall GC; Pauly RA
Am J Health Syst Pharm; 2008 Jan; 65(2):150-3. PubMed ID: 18192261
[TBL] [Abstract][Full Text] [Related]
17. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Ziedan A; Bhandari S
Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Safety Evaluation of a Pharmacist-Assisted Total Dose Iron Sucrose Protocol in Hospital Inpatients With Iron Deficiency Anemia.
Wall G; Sharma V; Taylor MJ; Schneider R; Adams K; Gasperi L; Lukenbill JC
J Pharm Pract; 2021 Aug; 34(4):573-576. PubMed ID: 31665957
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review.
Qassim A; Mol BW; Grivell RM; Grzeskowiak LE
Aust N Z J Obstet Gynaecol; 2018 Feb; 58(1):22-39. PubMed ID: 28921558
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Macdougall IC; Strauss WE; McLaughlin J; Li Z; Dellanna F; Hertel J
Clin J Am Soc Nephrol; 2014 Apr; 9(4):705-12. PubMed ID: 24458078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
